293 related articles for article (PubMed ID: 25819364)
1. Preparation and in vitro characterization of chitosan nanobubbles as theranostic agents.
Cavalli R; Argenziano M; Vigna E; Giustetto P; Torres E; Aime S; Terreno E
Colloids Surf B Biointerfaces; 2015 May; 129():39-46. PubMed ID: 25819364
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of dextran nanobubbles for oxygen delivery.
Cavalli R; Bisazza A; Giustetto P; Civra A; Lembo D; Trotta G; Guiot C; Trotta M
Int J Pharm; 2009 Nov; 381(2):160-5. PubMed ID: 19616610
[TBL] [Abstract][Full Text] [Related]
3. New chitosan nanobubbles for ultrasound-mediated gene delivery: preparation and in vitro characterization.
Cavalli R; Bisazza A; Trotta M; Argenziano M; Civra A; Donalisio M; Lembo D
Int J Nanomedicine; 2012; 7():3309-18. PubMed ID: 22802689
[TBL] [Abstract][Full Text] [Related]
4. SPIO nanoparticle-stabilized PAA-F127 thermosensitive nanobubbles with MR/US dual-modality imaging and HIFU-triggered drug release for magnetically guided in vivo tumor therapy.
Huang HY; Hu SH; Hung SY; Chiang CS; Liu HL; Chiu TL; Lai HY; Chen YY; Chen SY
J Control Release; 2013 Nov; 172(1):118-127. PubMed ID: 23933522
[TBL] [Abstract][Full Text] [Related]
5. Novel DiR and SPIO nanoparticles embedded PEG-PLGA nanobubbles as a multimodalimaging contrast agent.
Luo B; Zhang H; Liu X; Rao R; Wu Y; Liu W
Biomed Mater Eng; 2015; 26 Suppl 1():S911-6. PubMed ID: 26406092
[TBL] [Abstract][Full Text] [Related]
6. Echogenic Glycol Chitosan Nanoparticles for Ultrasound-Triggered Cancer Theranostics.
Min HS; You DG; Son S; Jeon S; Park JH; Lee S; Kwon IC; Kim K
Theranostics; 2015; 5(12):1402-18. PubMed ID: 26681985
[TBL] [Abstract][Full Text] [Related]
7. Development of fluorous lipid-based nanobubbles for efficiently containing perfluoropropane.
Oda Y; Suzuki R; Mori T; Takahashi H; Natsugari H; Omata D; Unga J; Uruga H; Sugii M; Kawakami S; Higuchi Y; Yamashita F; Hashida M; Maruyama K
Int J Pharm; 2015 Jun; 487(1-2):64-71. PubMed ID: 25841568
[TBL] [Abstract][Full Text] [Related]
8. Effect of Bubble Concentration on the in Vitro and in Vivo Performance of Highly Stable Lipid Shell-Stabilized Micro- and Nanoscale Ultrasound Contrast Agents.
Abenojar EC; Nittayacharn P; de Leon AC; Perera R; Wang Y; Bederman I; Exner AA
Langmuir; 2019 Aug; 35(31):10192-10202. PubMed ID: 30913884
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound responsive Gd-DOTA/doxorubicin-loaded nanodroplet as a theranostic agent for magnetic resonance image-guided controlled release drug delivery of melanoma cancer.
Maghsoudinia F; Akbari-Zadeh H; Aminolroayaei F; Birgani FF; Shanei A; Samani RK
Eur J Pharm Sci; 2022 Jul; 174():106207. PubMed ID: 35577179
[TBL] [Abstract][Full Text] [Related]
10. Nanobubbles: a promising efficient tool for therapeutic delivery.
Cavalli R; Soster M; Argenziano M
Ther Deliv; 2016; 7(2):117-38. PubMed ID: 26769397
[TBL] [Abstract][Full Text] [Related]
11. Preparation of nanobubbles for ultrasound imaging and intracelluar drug delivery.
Wang Y; Li X; Zhou Y; Huang P; Xu Y
Int J Pharm; 2010 Jan; 384(1-2):148-53. PubMed ID: 19781609
[TBL] [Abstract][Full Text] [Related]
12. Biomimetic Acoustically-Responsive Vesicles for Theranostic Applications.
Hsieh CC; Kang ST; Lin YH; Ho YJ; Wang CH; Yeh CK; Chang CW
Theranostics; 2015; 5(11):1264-74. PubMed ID: 26379791
[TBL] [Abstract][Full Text] [Related]
13. A Novel Approach to Making the Gas-Filled Liposome Real: Based on the Interaction of Lipid with Free Nanobubble within the Solution.
Tian J; Yang F; Cui H; Zhou Y; Ruan X; Gu N
ACS Appl Mater Interfaces; 2015 Dec; 7(48):26579-84. PubMed ID: 26567461
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin loaded superparamagnetic PLGA-iron oxide multifunctional microbubbles for dual-mode US/MR imaging and therapy of metastasis in lymph nodes.
Niu C; Wang Z; Lu G; Krupka TM; Sun Y; You Y; Song W; Ran H; Li P; Zheng Y
Biomaterials; 2013 Mar; 34(9):2307-17. PubMed ID: 23276658
[TBL] [Abstract][Full Text] [Related]
15. Theranostic Fibers for Simultaneous Imaging and Drug Delivery.
Jin M; Yu DG; Geraldes CF; Williams GR; Bligh SW
Mol Pharm; 2016 Jul; 13(7):2457-65. PubMed ID: 27280491
[TBL] [Abstract][Full Text] [Related]
16. Targeted Soft Biodegradable Glycine/PEG/RGD-Modified Poly(methacrylic acid) Nanobubbles as Intelligent Theranostic Vehicles for Drug Delivery.
Li Y; Wan J; Zhang Z; Guo J; Wang C
ACS Appl Mater Interfaces; 2017 Oct; 9(41):35604-35612. PubMed ID: 28967258
[TBL] [Abstract][Full Text] [Related]
17. First in vivo MRI study on theranostic dendrimersomes.
Filippi M; Catanzaro V; Patrucco D; Botta M; Tei L; Terreno E
J Control Release; 2017 Feb; 248():45-52. PubMed ID: 28069551
[TBL] [Abstract][Full Text] [Related]
18. Magnetic nanobubbles with potential for targeted drug delivery and trimodal imaging in breast cancer: an in vitro study.
Song W; Luo Y; Zhao Y; Liu X; Zhao J; Luo J; Zhang Q; Ran H; Wang Z; Guo D
Nanomedicine (Lond); 2017 May; 12(9):991-1009. PubMed ID: 28327075
[TBL] [Abstract][Full Text] [Related]
19. Perfluoropentane-filled chitosan poly-acrylic acid nanobubbles with high stability for long-term ultrasound imaging
Gao X; Guo D; Mao X; Shan X; He X; Yu C
Nanoscale; 2021 Mar; 13(10):5333-5343. PubMed ID: 33659972
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin-loaded nanobubbles: A new platform for controlled antibiotic delivery against methicillin-resistant Staphylococcus aureus infections.
Argenziano M; Banche G; Luganini A; Finesso N; Allizond V; Gulino GR; Khadjavi A; Spagnolo R; Tullio V; Giribaldi G; Guiot C; Cuffini AM; Prato M; Cavalli R
Int J Pharm; 2017 May; 523(1):176-188. PubMed ID: 28330735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
